Breaking News Instant updates and real-time market news.

AVXS

AveXis

$115.91

-3.69 (-3.09%)

, NVS

Novartis

$80.80

0.6 (0.75%)

11:25
04/09/18
04/09
11:25
04/09/18
11:25

Novartis to hold a conference call

Management discusses the agreement to acquire AveXis on a conference call to be held on April 9 at 12 pm. Webcast Link

AVXS

AveXis

$115.91

-3.69 (-3.09%)

NVS

Novartis

$80.80

0.6 (0.75%)

  • 09

    Apr

  • 23

    Apr

  • 17

    May

AVXS AveXis
$115.91

-3.69 (-3.09%)

04/09/18
MSCO
04/09/18
DOWNGRADE
MSCO
Equal Weight
AveXis downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst David Lebowitz downgraded AveXis (AVXS) to Equal Weight from Overweight following its announcement of an agreement to be acquired by Novartis (NVS) for $218 per share. He added that the buyout premium AveXis garnered should benefit Regenxbio (RGNX) as well.
04/09/18
WBLR
04/09/18
DOWNGRADE
WBLR
Market Perform
AveXis downgraded to Market Perform from Outperform at William Blair
William Blair analyst Raju Prasad downgraded AveXis (AVXS) to Market Perform after the company reached an agreement to be acquired by Novartis (NVS).
04/09/18
JEFF
04/09/18
NO CHANGE
JEFF
Jefferies highlights other gene theraphy players after AveXis takeover
Novartis' (NVS) deal to acquire AveXis (AVXS) for $8.7B should remind investors about the ongoing attractiveness within smid-cap biotech, Jefferies analyst Michael Yee tells investors in a research note. Novartis' two large gene therapy deals in four months will lead to a question of "who's next," the analyst adds. Yee says other mid-late stage gene therapy players include Bluebird Bio (BLUE), Spark Therapeutics (ONCE), BioMarin (BMRN), Abeona Therapeutics (ABEO), Regenxbio (RGNX), Nightstar Therapeutics (NITE) and Voyager Therapeutics (VYGR).
04/09/18
JEFF
04/09/18
NO CHANGE
JEFF
Buy
Jefferies ponders other potential suitors for AveXis after Novartis deal
Jefferies analyst Biren Amin asks who else can jump into the mix after AveXis (AVXS) agreed to be acquired by Novartis (NVS) for $218 per share in an all-cash deal. The analyst, who does not expect anti-trust issues to arise with the deal on the table, notes the speculation that Biogen (BIIB) may need to evaluate AveXis at some point. The Novartis deal could be the "trigger that forces it to do so," Amin writes in a research note. Further, the analyst has always felt Roche (RHHBY) could have an interest in AveXis given its development program with RG7916. He points out that AveXis Chairman Dan Welch was the CEO of Intermune when Roche purchased the company in 2014 for $8.3B. AveXis in premarket trading is up 81%, or $94.14, to $210.05.
NVS Novartis
$80.80

0.6 (0.75%)

TODAY'S FREE FLY STORIES

01:45
08/14/18
08/14
01:45
08/14/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap:…

BCE

BCE

$40.57

0.045 (0.11%)

21:57
08/13/18
08/13
21:57
08/13/18
21:57
Upgrade
BCE rating change at Edward Jones »

BCE upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$13.96

-0.11 (-0.78%)

21:55
08/13/18
08/13
21:55
08/13/18
21:55
Downgrade
Switch rating change at Raymond James »

Switch downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

FDC

First Data

$23.90

-0.78 (-3.16%)

21:55
08/13/18
08/13
21:55
08/13/18
21:55
Syndicate
First Data 64M share Secondary priced at $23.75 »

Citi acted as lead book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 14

    Aug

ARDS

Aridis Pharmaceuticals

$0.00

(0.00%)

21:54
08/13/18
08/13
21:54
08/13/18
21:54
Syndicate
Aridis Pharmaceuticals 2M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

JPM

JPMorgan

$113.88

-1.8 (-1.56%)

20:52
08/13/18
08/13
20:52
08/13/18
20:52
Periodicals
JPMorgan to stop offering investment accounts to foreign clients, Bloomberg says »

JPMorgan will discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

BIIB

Biogen

$340.67

-2.54 (-0.74%)

20:47
08/13/18
08/13
20:47
08/13/18
20:47
Periodicals
UK's NICE: Biogen's Spinraza too expensive for health service, Reuters reports »

U.K.'s National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

HD

Home Depot

$194.11

-2.19 (-1.12%)

, TPR

Tapestry

$47.42

-0.52 (-1.08%)

20:25
08/13/18
08/13
20:25
08/13/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

HD

Home Depot

$194.11

-2.19 (-1.12%)

TPR

Tapestry

$47.42

-0.52 (-1.08%)

AAP

Advance Auto Parts

$144.79

-1.52 (-1.04%)

EAT

Brinker

$43.81

-0.37 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 12

    Sep

HIL

Hill International

$5.65

(0.00%)

19:45
08/13/18
08/13
19:45
08/13/18
19:45
Hot Stocks
Hill International provides update on NYSE notice of delisting »

Hill Internationa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NVDA

Nvidia

$256.08

1.38 (0.54%)

19:36
08/13/18
08/13
19:36
08/13/18
19:36
Hot Stocks
Nvidia launches Turing GPU architecture in computer graphics »

NVIDIA today reinvented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

ESRX

Express Scripts

$84.04

0.39 (0.47%)

, CI

Cigna

$181.78

-1.59 (-0.87%)

19:33
08/13/18
08/13
19:33
08/13/18
19:33
Hot Stocks
Carl Icahn says will no longer vote against Cigna/Express Scripts deal »

Today Carl Icahn released…

ESRX

Express Scripts

$84.04

0.39 (0.47%)

CI

Cigna

$181.78

-1.59 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 24

    Aug

  • 24

    Aug

MEOH

Methanex

$71.55

-0.45 (-0.63%)

19:17
08/13/18
08/13
19:17
08/13/18
19:17
Hot Stocks
Methanex signs natural gas supply agreement for Chile operations »

Methanex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERY

Perry Ellis

$29.10

-0.03 (-0.10%)

19:16
08/13/18
08/13
19:16
08/13/18
19:16
Periodicals
Randa nearing decision on competing Perry Ellis bid, WWD reports »

Randa is in talks with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCBK

TriCo Bancshares

$39.20

-0.14 (-0.36%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Hot Stocks
TriCo Bancshares names Peter Wiese as CFO, effective August 14 »

TriCo Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 07

    Nov

ARQL

ArQule

$5.67

0.21 (3.85%)

, YEXT

Yext

$22.57

-0.18 (-0.79%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: ArQule (ARQL) up…

ARQL

ArQule

$5.67

0.21 (3.85%)

YEXT

Yext

$22.57

-0.18 (-0.79%)

CWT

California Water Service

$40.05

-0.4 (-0.99%)

SJW

SJW Corp.

$62.49

0.74 (1.20%)

VERI

Veritone

$15.81

1.05 (7.11%)

SWCH

Switch

$13.96

-0.11 (-0.78%)

VIPS

Vipshop

$8.98

-0.15 (-1.64%)

SAIL

SailPoint

$28.39

-0.43 (-1.49%)

RH

RH

$151.63

7.175 (4.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 13

    Aug

  • 14

    Aug

  • 04

    Sep

  • 04

    Sep

  • 10

    Sep

  • 16

    Aug

ROSE

Rosehill Resources

$8.36

-0.09 (-1.07%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Earnings
Rosehill Resources reports Q2 net income $8.7M vs. loss ($1.4M) last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

CMC

Commercial Metals

$21.80

0.11 (0.51%)

18:49
08/13/18
08/13
18:49
08/13/18
18:49
Upgrade
Commercial Metals rating change at Goldman Sachs »

Commercial Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

KALU

Kaiser Aluminum

$109.76

-1.35 (-1.22%)

18:44
08/13/18
08/13
18:44
08/13/18
18:44
Downgrade
Kaiser Aluminum rating change at Goldman Sachs »

Kaiser Aluminum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTA

Establishment Labs

$27.10

0.66 (2.50%)

18:09
08/13/18
08/13
18:09
08/13/18
18:09
Initiation
Establishment Labs initiated at BTIG »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

BRK.A

Berkshire Hathaway

$310,200.00

-1950 (-0.62%)

, BRK.B

Berkshire Hathaway

$205.17

-1.365 (-0.66%)

18:08
08/13/18
08/13
18:08
08/13/18
18:08
Hot Stocks
Berkshire Hathaway comments on quarterly reporting on Form 13F »

"Tomorrow afternoon,…

BRK.A

Berkshire Hathaway

$310,200.00

-1950 (-0.62%)

BRK.B

Berkshire Hathaway

$205.17

-1.365 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRO

Pros Holdings

$39.80

-0.2 (-0.50%)

18:06
08/13/18
08/13
18:06
08/13/18
18:06
Syndicate
PROS Holdings 450K share Block Trade; price range $7.60-$7.80 »

Barclays is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 14

    Aug

  • 20

    Aug

  • 21

    Aug

  • 16

    Aug

YY

YY

$87.72

-1.09 (-1.23%)

18:06
08/13/18
08/13
18:06
08/13/18
18:06
Earnings
Breaking Earnings news story on YY »

YY sees Q3 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 10

    Sep

ICUI

ICU Medical

$293.00

0.85 (0.29%)

18:05
08/13/18
08/13
18:05
08/13/18
18:05
Syndicate
ICU Medical 700K share Block Trade; price range $287-$290 »

Barclays is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

YY

YY

$87.72

-1.09 (-1.23%)

18:05
08/13/18
08/13
18:05
08/13/18
18:05
Earnings
YY reports Q2 adjusted EPS $2.03, consensus $1.77 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 10

    Sep

LAC

Lithium Americas

$3.56

-0.17 (-4.56%)

, SQM

SQM

$45.68

-1.16 (-2.48%)

18:03
08/13/18
08/13
18:03
08/13/18
18:03
Hot Stocks
Lithium Americas to partner with Ganfeng Lithium in Cauchari-Olaroz »

Lithium Americas (LAC) is…

LAC

Lithium Americas

$3.56

-0.17 (-4.56%)

SQM

SQM

$45.68

-1.16 (-2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.